338 filings
Page 7 of 17
8-K
4hs14q ix
7 Nov 19
Pacira BioSciences Reports Third Quarter 2019 Financial Results and Business Update
8:05am
8-K
qdi4dcdr771lidt
19 Sep 19
Departure of Directors or Certain Officers
4:30pm
S-8
1laglvobin
8 Aug 19
Registration of securities for employees
4:53pm
8-K
ih43zox fuuu
8 Aug 19
Pacira BioSciences Reports Second Quarter 2019 Financial Results and Business Update
8:03am
8-K/A
fqzbxh 25qua5
25 Jun 19
Financial Statements and Exhibits
4:34pm
8-K
7nm f8u713hg
19 Jun 19
Pacira BioSciences Appoints Former Johnson & Johnson Executive, Max Reinhardt, as President
8:00am
8-K
l7tlhto14
7 Jun 19
Departure of Directors or Certain Officers
4:10pm
8-K
111ele ines5abn9rjy7
2 May 19
Pacira BioSciences Reports First Quarter 2019 Revenues of $91.3 Million
8:05am
DEFA14A
jsxivw571bv5whmr
22 Apr 19
Additional proxy soliciting materials
4:22pm
CT ORDER
f9yykk2gjxw 2k3ql7
15 Apr 19
Confidential treatment order
2:57pm
8-K
a2aeue zy
9 Apr 19
Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System
4:15pm
CT ORDER
9op qchq0
11 Mar 19
Confidential treatment order
2:37pm
8-K
e5brx
5 Mar 19
Pacira to Acquire MyoScience, Adding FDA-approved ioveraº System for Non-opioid Pain Control
7:30am
8-K
skqhh31dzlgksr
28 Feb 19
Pacira Reports Record Fourth Quarter and Full Year Revenues
8:02am
8-K
x5mkfc2q590i
3 Jan 19
Pacira Reports Preliminary 2018 Net EXPAREL® Sales of $331 Million
7:35am